Antimicrobial Activity Evaluation on Silver Doped Hydroxyapatite/Polydimethylsiloxane Composite Layer. - sprookjes - yvandenbroek - TriplyDB

Antimicrobial Activity Evaluation on Silver Doped Hydroxyapatite/Polydimethylsiloxane Composite Layer.

Antimicrobial Activity Evaluation on Silver Doped Hydroxyapatite/Polydimethylsiloxane Composite Layer.

http://www.wikidata.org/entity/Q33466403

about

Lactococcus lactis as a safe and inexpensive source of bioactive silver composites.Structural and Biological Assessment of Zinc Doped Hydroxyapatite Nanoparticles Structural and Antimicrobial Evaluation of Silver Doped Hydroxyapatite-Polydimethylsiloxane Thin Layers

P2860

Q41314912-5E8D3177-BB2F-4D59-AD75-12E5C1149048 Q58110840-5EB12AD2-6404-4D2D-9837-5DFCF2BA95E5 Q59146770-88888B52-DE12-472A-8517-B10EB3C9DB45

P2860

Antimicrobial Activity Evaluation on Silver Doped Hydroxyapatite/Polydimethylsiloxane Composite Layer.

http://www.wikidata.org/entity/Q33466403

description

2015 nî lūn-bûn

@nan

2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Antimicrobial Activity Evaluat ...... ethylsiloxane Composite Layer.

@ast

Antimicrobial Activity Evaluat ...... ethylsiloxane Composite Layer.

@en

type

label

Antimicrobial Activity Evaluat ...... ethylsiloxane Composite Layer.

@ast

Antimicrobial Activity Evaluat ...... ethylsiloxane Composite Layer.

@en

prefLabel

Antimicrobial Activity Evaluat ...... ethylsiloxane Composite Layer.

@ast

Antimicrobial Activity Evaluat ...... ethylsiloxane Composite Layer.

@en

P1433

Q33466403-3D73F1B8-B93D-42E6-9328-23339EDEA1D4

P1476

Q33466403-FD47550F-88D8-439D-8C08-0E1C299C2A40

P2093

Q33466403-1779A79A-7D4D-46CA-B4B0-675FD7EE4736

Q33466403-225E9BF6-13C4-4D45-8DDE-3CAAE8CD6D61

Q33466403-3544009C-E6E2-4560-8FE9-0713B990DF1C

Q33466403-61AC17AF-4AB3-40E1-A0CE-5DC022BA1B5F

Q33466403-78273CA6-4327-4A85-8A3C-F52C3A76BB10

Q33466403-89AD4B7F-0C6A-4AE1-9143-4AC303F669EF

Q33466403-BDFD642E-E7C0-4E93-B336-334FCD226A09

Q33466403-DF2408CC-8129-4CCE-BAE0-28E4DCBC538A

Q33466403-EA0F7CDF-C387-47DC-8E10-F3E8A4C2F0A1

Q33466403-EBAEE7AE-8B06-429B-8F5C-C23694349439

P2860

Q33466403-006AE073-A6F7-44EA-965D-CBA021A88E44

Q33466403-0BAB006B-F0F3-4447-9F3D-CB64865373CF

Q33466403-0DE35E6C-5CA0-4743-8931-3FA186D6D718

Q33466403-0F65BC60-5250-49FA-8206-BE51E9C68828

Q33466403-15324BF3-5BED-4B5C-BCFB-4038AC9F82EF

Q33466403-1A454F2F-C610-424C-AFCF-2ED209779F8E

Q33466403-1A5583F9-4631-4E89-88A4-86B305FFC678

Q33466403-2110F40C-8B90-47F6-9D78-4A62A3374383

Q33466403-2D05EFB5-6C8B-4329-BD24-BFF798EEAB20

Q33466403-2D703EAC-D4A6-464E-8257-96CA9D1696AA

P304

Q33466403-9C3D97CD-2983-4B2E-913E-AC612BBF11E7

P31

Q33466403-16A292FE-A5E3-4206-8CFE-A40D43784E52

P356

Q33466403-E35945F5-4F56-4CF0-8DFD-69CD139DF24B

P407

Q33466403-D26AC904-4FF3-43FF-BB3C-E043E3B6EAEE

P478

Q33466403-ACE73D5B-6177-4AD6-AF98-BD0DF6F14282

P50

Q33466403-7DD78D4F-9AFA-49AB-ACC5-7DE2ABF12E10

Q33466403-950DD8A8-F1AA-4244-9E24-5CDF17C681DF

P577

Q33466403-BA7231D8-E3EE-4233-BE1E-8B7DFB1901EC

P5875

Q33466403-FC43324C-F97B-4D8C-869C-4DFA971EAC52

P698

Q33466403-829772A5-CEBF-4926-82A2-E1349FA0CAB4

P932

Q33466403-55A9386B-6743-4E7A-A50F-EF0BBA17CFF2

P356

P1433

BioMed Research International

P1476

Antimicrobial Activity Evaluat ...... methylsiloxane Composite Layer

@en

P2093

A Groza

http://www.w3.org/2001/XMLSchema#string

C S Ciobanu

http://www.w3.org/2001/XMLSchema#string

D Predoi

http://www.w3.org/2001/XMLSchema#string

G A Stanciu

http://www.w3.org/2001/XMLSchema#string

M C Chifiriuc

http://www.w3.org/2001/XMLSchema#string

M Ganciu

http://www.w3.org/2001/XMLSchema#string

P Chapon

http://www.w3.org/2001/XMLSchema#string

R Hristu

http://www.w3.org/2001/XMLSchema#string

R V Ghita

http://www.w3.org/2001/XMLSchema#string

S L Iconaru

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of mucosal Candida albicans biofilms

International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobia

Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance

Characteristics of biofilm formation by Candida albicans.

Effect of surface modification on the in vitro calcium phosphate growth on the surface of poly(methyl methacrylate) and bioactivity.

Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient.

Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients

Intravascular catheter-associated infections.

Factors influencing adherence of Candida spp. to host tissues and plastic surfaces.

Hybrid magnetite nanoparticles/Rosmarinus officinalis essential oil nanobiosystem with antibiofilm activity.

P304

926513

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/926513

http://www.w3.org/2001/XMLSchema#string

P407

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283872069

http://www.w3.org/2001/XMLSchema#string

P698

26504849

http://www.w3.org/2001/XMLSchema#string

P932

4609430

http://www.w3.org/2001/XMLSchema#string